The Latest: Panel studies illness cause in vaccine trial
|
October 13, 2020 10:30 AM
NEW BRUNSWICK, N.J. — Johnson & Johnson executives say it will be a few days before they know more about an unexplained illness in one participant that caused a temporary pause in its late-stage COVID-19 vaccine study.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
